Neuroblastoma is the most common cancer diagnosed in infancy, arising from immature nerve cells and most often found in the adrenal glands, abdomen, chest, or neck. Because it is typically diagnosed before a child's second birthday, the emotional weight of a neuroblastoma diagnosis falls almost entirely on parents in the earliest years, then shifts toward the child's own long-term wellbeing as they grow older. Two recent studies illustrate just how different those two chapters of mental health impact look in practice.
What Research Shows: Parents and Treatment Adherence
A 2026 study of 350 families at four children's hospitals across China followed parents of children with neuroblastoma through standardized measures of parenting stress, depression, and family functioning, alongside a validated scale of how well families followed their child's treatment plan. Parental distress overall was significantly linked to lower treatment adherence, and poor family functioning made families nearly three times more likely to fall short on their child's care plan. The single strongest independent predictor of non-adherence, though, was not overall parental stress; it was paternal depressive symptoms specifically, which more than doubled the odds of poor adherence. That finding sits alongside a striking contrast: mothers reported significantly higher parenting stress than fathers throughout the study. In other words, mothers carried the heavier day-to-day emotional load, but it was depression in fathers that most reliably predicted whether a child's treatment stayed on track.
Coping as a Parent of a Child With Neuroblastoma
- Don't assume the most visibly stressed parent needs the most support Research on families managing neuroblastoma found that fathers' depressive symptoms, not mothers' reported stress levels, most strongly predicted whether a child's treatment plan was followed. Quieter distress can matter just as much as visible distress.
- Treat family functioning as part of your child's treatment plan Studies found that how well a family communicates and solves problems together was directly linked to treatment adherence, so working on family communication isn't a distraction from your child's care; it supports it.
- Make space for both parents to be asked how they're doing, not just the primary caregiver Clinical attention often goes to whichever parent is most visibly stressed, but the data suggests that checking in on both parents' mental health, including fathers who are often not asked, matters directly for the child's outcomes.
- Ask directly about practical barriers to following the treatment plan Because family functioning and parental distress were both tied to treatment adherence, a conversation about what's actually making a medication schedule or follow-up visit hard can surface fixable logistical problems, not just emotional ones.
- Build in extra support for the earliest, most intense period after diagnosis Because neuroblastoma is typically diagnosed in infancy, the earliest period often overlaps with new-parent exhaustion and basic caregiving demands, compounding the load in a way that's distinct from a diagnosis later in childhood.
Long After Treatment: How Survivors Fare Years Later
A separate study tracked 859 childhood neuroblastoma survivors into their teens and twenties, most of whom had been diagnosed before their first birthday, comparing them with 872 of their own siblings. Compared with siblings, survivors showed higher rates of impairment across the board: anxiety or depression symptoms in 19% versus 14% of siblings, attention problems in 21% versus 13%, and peer conflict or social withdrawal in 26% versus 17%. But the specific chemotherapy drugs used in treatment were not linked to these outcomes. What did predict psychological impairment was something more indirect: survivors living with two or more chronic health conditions, especially lung-related or hormone-related complications, were significantly more likely to struggle emotionally and behaviorally, and that struggle was in turn linked to needing special education services and completing less schooling as adults.
Why the Chemotherapy Itself Isn't the Main Driver
This is a meaningful distinction for families to hold onto: it was not exposure to specific treatments like vincristine, cisplatin, or retinoic acid that predicted later psychological struggles, but rather the accumulation of ongoing physical health problems after treatment ended. That reframes the long-term mental health conversation away from which drugs a child received and toward something more actionable: survivors with ongoing physical complications, particularly breathing or hormonal issues, are the group most likely to benefit from early, proactive mental health screening and support, even years after treatment is complete.
Practical Steps
- If your child has lingering physical health issues after treatment, ask for a mental health check-in too Survivors with two or more chronic health conditions after neuroblastoma treatment showed meaningfully higher rates of anxiety, depression, and attention problems, so ongoing physical complications are a cue to check in on emotional wellbeing as well.
- Don't assume distress based on which chemotherapy drugs your child received Research specifically found no link between common treatment drugs and later psychological impairment, so there's no need to brace for distress based on treatment history alone; focus instead on how your child is actually doing now.
- If a child is struggling in school, ask whether emotional or behavioral symptoms are part of the picture Psychological impairment in survivors was directly linked to higher use of special education services and lower educational attainment, so academic struggles are worth exploring from a mental health angle, not only an academic one.
- For fathers specifically: don't wait to be asked how you're doing Paternal depressive symptoms were the single strongest predictor of whether a young child's neuroblastoma treatment stayed on track, yet fathers are often not the parent clinical attention defaults to.
- Look into family-focused support, not just individual counseling Because family functioning as a whole was tied to treatment adherence, support that strengthens communication and problem-solving between parents may help in ways that one-on-one therapy alone does not.